5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      EAE: imperfect but useful models of multiple sclerosis.

      Trends in Molecular Medicine

      Animals, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental, immunology, pathology, therapy, Humans, Immunotherapy, Multiple Sclerosis, Primates, Rodentia

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The high failure rate of immunotherapies in multiple sclerosis (MS) clinical trials demonstrates problems in translating new treatment concepts from animal models to the patient. One main reason for this 'immunotherapy gap' is the usage of immunologically immature, microbiologically clean and genetically homogeneous rodent strains. Another reason is the artificial nature of the experimental autoimmune encephalomyelitis model, which favors CD4+ T cell driven autoimmune mechanisms, whereas CD8+ T cells are prevalent in MS lesions. In this paper, we discuss preclinical models in humanized rodents and non-human primates that are genetically closer to MS. We also discuss models that best reproduce specific aspects of MS pathology and how these can potentially improve preclinical selection of promising therapies from the discovery pipeline. Copyright © 2010 Elsevier Ltd. All rights reserved.

          Related collections

          Author and article information

          Journal
          21251877
          10.1016/j.molmed.2010.11.006

          Comments

          Comment on this article